Abstract
The retraction has been agreed due to duplications within Figure 2 and the inclusion of figure elements in Figure 1 and 2 that were previously published [1‐4]. Thus, the conclusions of this article are considered invalid. The authors have been informed of the decision to retract but did not agree with it.References:1. Hanaa H. Ahmeda, Wafaa Gh. Shoushab, El‐Sayed M. El‐Sayed Mahdyb, Laila A. Rashedc, Sara M. Abdob (2013), Influence of adipose tissue derived mesenchymal stem cells in combination with injectable bone substitute on osteoclastogenesis in osteoporotic rats. J Appl Pharm Sci, 3: 046‐056. https://doi.org/10.7324/JAPS.2013.38092. Salem, A.M., Ahmed, H.H., Atta, H.M., Ghazy, M.A. and Aglan, H.A. (2014), RETRACTED: Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell Biol Int, 38: 1367‐1383. https://doi.org/10.1002/cbin.103313. Ahmed H, Salem A, Atta H, Ghazy M, Aglan H. RETRACTED: Do adipose tissue‐derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Human & Experimental Toxicology. 2014;33(12):1217‐1231. doi: 10.1177/09603271145242384. Ahmed, H.H., Metwally, F.M., Khalil, W.K.B. et al. Bone marrow derived mesenchymal stem cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochem. J. 9, 284–294 (2015). https://doi.org/10.1134/S1819712415040029